Maximus, Inc. (NYSE:MMS) Director Paul R. Lederer sold 2,200 shares of the firm’s stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $60.87, for a total value of $133,914.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Shares of Maximus, Inc. (NYSE:MMS) traded up 0.67% on Monday, hitting $61.24. The stock had a trading volume of 63,392 shares. Maximus, Inc. has a one year low of $43.69 and a one year high of $64.97. The stock has a market capitalization of $3.97 billion, a PE ratio of 19.63 and a beta of 1.39. The firm’s 50 day moving average is $61.19 and its 200-day moving average is $60.86.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.76 by $0.03. The firm had revenue of $600.40 million for the quarter, compared to the consensus estimate of $614.12 million. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The business’s revenue was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.79 earnings per share. Equities research analysts expect that Maximus, Inc. will post $3.12 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 31st. Shareholders of record on Tuesday, August 15th will be given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date is Friday, August 11th. Maximus’s dividend payout ratio (DPR) is presently 5.73%.

ILLEGAL ACTIVITY NOTICE: “Maximus, Inc. (NYSE:MMS) Director Sells $133,914.00 in Stock” was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US & international copyright legislation. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/14/maximus-inc-nysemms-director-sells-133914-00-in-stock.html.

A number of research analysts have recently commented on MMS shares. Canaccord Genuity lowered Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective on the stock. in a report on Tuesday, July 4th. Jefferies Group LLC lowered Maximus from a “buy” rating to a “hold” rating and increased their price objective for the company from $63.00 to $64.00 in a report on Friday, May 5th. Maxim Group lowered Maximus from a “buy” rating to a “hold” rating and set a $66.00 price objective on the stock. in a report on Thursday, May 4th. They noted that the move was a valuation call. ValuEngine lowered Maximus from a “buy” rating to a “hold” rating in a report on Tuesday, May 16th. Finally, KeyCorp reissued a “sector weight” rating on shares of Maximus in a report on Thursday, May 25th. One research analyst has rated the stock with a sell rating and eight have issued a hold rating to the company. The stock currently has an average rating of “Hold” and an average price target of $62.17.

A number of institutional investors have recently made changes to their positions in MMS. American International Group Inc. increased its position in shares of Maximus by 4.1% in the first quarter. American International Group Inc. now owns 166,652 shares of the health services provider’s stock worth $10,366,000 after buying an additional 6,634 shares during the period. Louisiana State Employees Retirement System increased its position in shares of Maximus by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the health services provider’s stock worth $1,020,000 after buying an additional 400 shares during the period. Navellier & Associates Inc increased its position in shares of Maximus by 10.9% in the first quarter. Navellier & Associates Inc now owns 8,737 shares of the health services provider’s stock worth $543,000 after buying an additional 856 shares during the period. Advantus Capital Management Inc increased its position in shares of Maximus by 3.1% in the first quarter. Advantus Capital Management Inc now owns 8,298 shares of the health services provider’s stock worth $516,000 after buying an additional 248 shares during the period. Finally, OppenheimerFunds Inc. increased its position in shares of Maximus by 19.5% in the first quarter. OppenheimerFunds Inc. now owns 11,010 shares of the health services provider’s stock worth $685,000 after buying an additional 1,793 shares during the period. 97.20% of the stock is currently owned by hedge funds and other institutional investors.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.